Bright Minds Biosciences Ownership | Who Owns Bright Minds Biosciences?
Bright Minds Biosciences Ownership Summary
Bright Minds Biosciences is owned by 15.33% institutional investors, 11.56% insiders, and 73.11% retail investors. Janus henderson group is the largest institutional shareholder, holding 16.55% of DRUG shares. iShares Russell 2000 ETF is the top mutual fund, with 1.68% of its assets in Bright Minds Biosciences shares.
DRUG Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | Bright Minds Biosciences | 15.33% | 11.56% | 73.11% |
| Sector | Healthcare Stocks | 35.74% | 11.83% | 52.43% |
| Industry | Biotech Stocks | 36.05% | 11.82% | 52.13% |
| Idea | Psychedelic Stocks List | 14.03% | 7.77% | 78.20% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Janus henderson group | 1.28M | 16.55% | $93.52M |
| Cormorant asset management, lp | 1.06M | 13.65% | $77.30M |
| Blackrock funding, inc. /de | 621.93K | 8.01% | $45.38M |
| Vivo capital | 557.17K | 7.18% | $40.66M |
| Braidwell lp | 539.71K | 6.95% | $39.38M |
| Adage capital partners gp | 495.74K | 6.39% | $36.17M |
| Vestal point capital, lp | 492.32K | 6.34% | $35.92M |
| Driehaus capital management | 432.51K | 5.57% | $31.56M |
| Perceptive advisors | 377.54K | 4.86% | $27.55M |
| Balyasny asset management | 297.16K | 3.83% | $21.68M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Acuta capital partners | 112.00K | 5.76% | $8.17M |
| Cormorant asset management, lp | 1.06M | 3.88% | $77.30M |
| Great point partners | 220.00K | 3.69% | $16.05M |
| B group | 67.50K | 3.65% | $4.93M |
| Vivo capital | 557.17K | 3.39% | $40.66M |
| Braidwell lp | 539.71K | 1.31% | $39.38M |
| Bioimpact capital | 212.18K | 1.20% | $15.48M |
| Vestal point capital, lp | 492.32K | 1.00% | $35.92M |
| Ikarian capital | 166.65K | 0.99% | $12.16M |
| Sio capital management | 86.08K | 0.90% | $6.28M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Vestal point capital, lp | 492.32K | 1.00% | 492.32K |
| Deerfield management company, l.p. (series c) | 283.00K | 0.24% | 283.00K |
| Ra capital management | 265.00K | 0.20% | 265.00K |
| Blackrock funding, inc. /de | 621.93K | 0.00% | 227.89K |
| Great point partners | 220.00K | 3.69% | 220.00K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Logos global management lp | - | - | -245.00K |
| Millennium management | 52.83K | 0.00% | -141.60K |
| Stempoint capital lp | - | - | -97.34K |
| Perceptive advisors | 377.54K | 0.54% | -71.75K |
| Superstring capital management lp | 13.31K | 0.69% | -33.97K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Vestal point capital, lp | 492.32K | 1.00% | 492.32K | $35.92M |
| Deerfield management company, l.p. (series c) | 283.00K | 0.24% | 283.00K | $20.65M |
| Ra capital management | 265.00K | 0.20% | 265.00K | $19.34M |
| Great point partners | 220.00K | 3.69% | 220.00K | $16.05M |
| B group | 67.50K | 3.65% | 67.50K | $4.93M |
Sold Out
| Holder | Change |
|---|---|
| Pnc financial services group | -9.00 |
| Srs capital advisors | -24.00 |
| Us bancorp \de\ | -26.00 |
| Farther finance advisors | -39.00 |
| National bank of canada /fi/ | -92.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 44 | -40.54% | 1,189,770 | -81.95% | 15 | 0.21% | 33 | -25.00% | 7 | -65.00% |
| Dec 31, 2025 | 50 | -20.63% | 3,721,548 | -38.39% | 51 | 0.71% | 27 | -30.77% | 16 | 23.08% |
| Sep 30, 2025 | 62 | 29.17% | 6,034,640 | 15.24% | 85 | 0.62% | 38 | 26.67% | 13 | 44.44% |
| Jun 30, 2025 | 48 | 41.18% | 5,236,756 | 0.37% | 117 | 0.86% | 30 | 50.00% | 9 | 12.50% |
| Mar 31, 2025 | 34 | 13.33% | 5,217,399 | 6.55% | 116 | 0.97% | 20 | -25.93% | 8 | 300.00% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| iShares Russell 2000 ETF | 164.78K | 1.68% | 1.41K |
| Janus Henderson Hrzn Biotec E2 USD | 146.89K | 1.50% | - |
| Heptagon Driehaus US Micro Cap Eq C$ Acc | 106.65K | 1.09% | 2.07K |
| Eventide Healthcare & Life Sciences I | 103.01K | 1.05% | 103.01K |
| BlackRock Health Sciences Opps Inv A | 95.66K | 0.98% | - |
| BGF World Healthscience A2 | 76.78K | 0.78% | - |
| iShares Russell 2000 Growth ETF | 56.90K | 0.58% | 146.00 |
| Fidelity Small Cap Index | 49.53K | 0.51% | 511.00 |
| Driehaus Micro Cap Growth USD | 42.01K | 0.43% | 11.16K |
| State St Russell Sm/Mid Cp® Indx SL Cl I | 40.34K | 0.41% | - |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Apr 28, 2026 | Cormorant Asset Management, LP | Former 10% Owner | Sell | $9.79M |
| Nov 04, 2024 | Cormorant Asset Management, LP | - | Buy | $4.00M |
| Oct 16, 2024 | Cormorant Asset Management, LP | - | Buy | $922.63K |
| Oct 15, 2024 | Cormorant Asset Management, LP | - | Buy | $224.60K |
| Oct 15, 2024 | Cormorant Asset Management, LP | - | Buy | $56.93K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | - | 1 |
| 2024 Q4 | 12 | - |
DRUG Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools